Head & Neck Cancer

Joshua Bauml, M.D., assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the potential of therapeutic vaccine in patients who have head and neck cancer.

Physical therapy can boost quality of life for patients with cancer, but it isn’t always prescribed.

Tailored survivorship care plans (SCPs) may be beneficial for survivors of head and neck cancer, according to recent research.

A recent study showed that patients with head and neck cancer who had greater depressive symptoms had shorter survival, higher rates of chemoradiation interruption and poorer treatment response. However, there are ways to manage these symptoms.

Oral mucositis causes pain, the inability to eat which can also lead to nutritional problems, and an increased risk for infection as a result of open sores. In turn, these symptoms can lead to reduced quality of life, chemotherapy or radiation dose-limiting, and increased treatment costs from antibiotics or narcotics or additional or longer hospital stays.

Looking back in 2018, I am so glad that we sought out the other opinions. Nerve wracking as it was, the process opened up other options we would not have known about.

“As the population of cancer survivors continues to grow, so does the importance of addressing the long-term sequelae of cancer treatment,” the authors wrote. “This hearing loss can result in multifaceted decrease in quality of life, and in pediatric patients it can impact social and academic development.”

Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.

Michael D. Becker, cancer survivor and author of “A Walk With Purpose: Memoir of a Bioentrepreneur” discusses how he realized that he had head and neck cancer.

Patients with head and neck squamous cell carcinoma (HNSCC) saw an improvement or stabilization in quality of life when they were treated with Opdivo.

Patients with squamous cell carcinoma of the head and neck (SCCHC) and those with melanoma saw some promising activity with the drug combination of epacadostat and Opdivo (nivolumab), according to findings from the phase 1/2 ECHO-204 study presented at the 2017 ASCO Annual Meeting.

Smoking is a risk factor for a number of different types of head and neck cancers, but quitting is not always easy.

Minimally invasive approaches are being explored to lower associated adverse events and, overall, improve patient outcomes for patients with head and neck cancer.

As the treatment landscape of head and neck cancer has changed significantly over the past year, immunotherapy has emerged as a key player in patient care.

The number of positive lymph nodes can help guide treatment for locally advanced head and neck cancer, according to a recent study.

"Telenutrition" programs can help high-risk patients who do not otherwise have access to a registered dietician, according to a recent study and program launched at the Carolinas HealthCare System.

Researchers at the University of Michigan are hoping to improve the survival rates for laryngeal cancer.

NFL Hall of Famer Jim Kelly discusses how cancer touched his family and his involvement in Your Cancer Game Plan.

There is a need to find biomarkers that may help predict recurrence in HPV+ oropharyngeal cancer, says Matthew E. Spector, M.D.

From publications to one-on-one interactions, SPOHNC offers caregivers, patients and survivors of oral, head and neck cancer support they need to navigate their diagnosis.